Clorox Full Year 2025 Results\n\nKey Financial Results\nRevenue: US$7.10b (flat on FY 2024). Net income: US$810.0m (up 189% from FY 2024). Profit margin: 11% (up from 3.9% in FY 2024). EPS: US$6.56 (up from US$2.26 in FY 2024).\n\nClorox EPS Beats Expectations\nRevenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 12%. The primary driver behind last 12 months revenue was the Health and Wellness segment contributing a total revenue of US$2.70b (38% of total revenue). Notably, cost of sales worth US$3.90b amounted to 55% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to US$1.13b (47% of total expenses). Looking ahead, revenue is forecast to grow 1.5% p.a. on average during the next 3 years, compared to a 2.8% growth forecast for the Household Products industry in the US. The company's shares are down 1.7% from a week ago.\n\nRisk Analysis\nYou should always think about risks. Case in point, we've spotted 1 warning sign for Clorox you should be aware of.\n\nAbout NYSE:CLX\nClorox manufactures and markets consumer and professional products worldwide. Established dividend payer and good value.\n\nSimilar Companies\nNasdaqGS:KMB - Kimberly-Clark\nNasdaqGS:REYN - Reynolds Consumer Products

Clorox Full Year 2025 Earnings: EPS Beats Expectations

Clorox reported its full-year 2025 financial results, showing a significant increase in net income and earnings per share (EPS). Revenue was flat compared to the previous year at $7.10 billion, while net income rose 189% to $810 million, driven by improved profit margins that increased to 11% from 3.9% in 2024. EPS reached $6.56, up from $2.26 in 2024, surpassing analyst expectations by 12%. The Health and Wellness segment contributed $2.70 billion in revenue, accounting for 38% of total revenue. Cost of sales at $3.90 billion represented 55% of total revenue, and general and administrative expenses totaled $1.13 billion, or 47% of total expenses. The company forecasts 1.5% annual revenue growth over the next three years, slightly below the 2.8% projected growth for the US Household Products industry. Clorox's shares declined by 1.7% from the previous week.